Opening book details…
Can I read Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development : Workshop Summary on EtoBox?
Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development : Workshop Summary by Institute of Medicine; Board on Health Sciences Policy; and Translation Development Forum on Drug Discovery; Anne B. Claiborne; Steve Olson is a medicine available to read on EtoBox.
What is Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development : Workshop Summary about?
The development and application of regulatory science - which FDA has defined as the science of developing new tools, standards, and approaches to assess the safety, efficacy, quality, and performance of FDA-regulated products - calls for a well-trained, scientifically engaged, and motivated workforce. FDA faces challenges in retaining regulatory scientists and providing them with opportunities for professional development. In the private sector, advancement of innovative regulatory science in d
Who reads Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development : Workshop Summary?
It is typically read by working professionals who need an authoritative practice reference.
Common subject areas: medicine, law, business, engineering.
- Author
- Institute of Medicine; Board on Health Sciences Policy; and Translation Development Forum on Drug Discovery; Anne B. Claiborne; Steve Olson
- Publisher
- National Academies Press
- Published
- 2012
- Language
- EN
- ISBN
- 9780309222174
- Category
- medicine
- Subjects
- Psychology, Technology, Science
- Updated
- 2026-03-25
More by Institute of Medicine; Board on Health Sciences Policy; and Translation Development Forum on Drug Discovery; Anne B. Claiborne; Steve Olson
Similar books
- Advancing Regulatory Science for Medical Countermeasure Development : Workshop Summary — Development, and Translation Forum on Drug Discovery, Forum on Medical and Public Health Preparedness for Catastrophic Events, Board on Health Sciences Policy, Institute of Medicine, Theresa Wizemann, Bruce M. Altevogt, Anne B. Claiborne (2011)
- Building a National Framework for the Establishment of Regulatory Science for Drug Development : Workshop Summary — Institute of Medicine; Board on Health Sciences Policy; Forum on Drug Discovery, Development, and Translation; Anne B. Claiborne; Rebecca A. English; Yeonwoo Lebovitz (2011)
- Rational Therapeutics for Infants and Children : Workshop Summary — Institute of Medicine; Division of Health Sciences Policy; Roundtable on Research and Development of Drugs, Biologics, and Medical Devices; Jonathan R. Davis; Sarah Pitluck; Peter Bouxsein; Ronald W. Estabrook; Sumner Yaffe, M.D (2000)
- Advancing the Discipline of Regulatory Science for Medical Product Development : an Update on Progress and a Forward-looking Agenda : Workshop Summary : Proceedings of a Workshop — and Medicine Engineering National Academies of Sciences; Health and Medicine Division; Board on Health Sciences Policy; and Translation Development Forum on Drug Discovery; Anne B. Claiborne; Amanda Wagner Gee; Morgan L. Bona (2016)
- International Regulatory Harmonization Amid Globalization of Drug Development : Workshop Summary — Weisfeld, Victoria D.; Lustig, Tracy A. (2013)
- Promising Practices for Strengthening the Regional Stem Workforce Development Ecosystem — Board on Higher Education and Workforce, Policy and Global Affairs, National Academies of Sciences, Engineering, and Medicine, Committee on Improving Higher Education's Responsiveness to STEM Workforce Needs: Identifying Analytical Tools and Regional Best Practices, Identifying Analytical Tools and Regional Best Practices Committee Improving Higher Education's Responsiveness to STEM Workforce Needs, National Academies of Sciences, Engineering, and Medicine Staff (2016)